Keyword: Singapore

Boehringer is swallowing Enleofen’s anti-IL-11 antibody platform, putting it on the hook for up to $1 billion in milestones per product. 

The chronicles of Aslan keep reading as a tragedy as the Singapore-based cancer biotech is hit with another failure for its key pipeline hope.

In a $72 million deal, Inex Innovations Exchange and Nova Satra will combine their laboratory, R&D and distribution arms.

The layoffs are expected to halve Aslan’s operational costs, extending its runway as it heads toward upcoming readouts.

Aslan has been hit by the news that its lead drug varlitinib missed the mark in a gastric cancer trial, sending its shares down almost 16%.

Johnson & Johnson Vision inked a $26.35 million collaboration with the Singapore Eye Research institute focused on treating nearsightedness.

Synthetic polymers invented by IBM, which killed five types of superbugs, could be the answer to antibiotic resistance.

Biosensorix's new collaboration will give it access to an electrochemical lateral flow immunosensor.

The product is a small titanium device that is implanted beneath the skin to provide access to an arteriovenous fistula.

Sequencing the genes of 116 houseflies led scientists in Singapore to propose using the insects as early warning systems for emerging outbreaks.